학술논문

Discovery and Verification of Extracellular miRNA Biomarkers for Non-invasive Prediction of Pre-eclampsia in Asymptomatic Women
Document Type
article
Source
Cell Reports Medicine. 1(2)
Subject
Reproductive Medicine
Biomedical and Clinical Sciences
Prevention
Biotechnology
Genetics
Contraception/Reproduction
Human Genome
Reproductive health and childbirth
Good Health and Well Being
Adult
Asymptomatic Diseases
Biomarkers
Case-Control Studies
Extracellular Vesicles
Female
Gestational Age
Humans
Maternal Serum Screening Tests
MicroRNAs
Pre-Eclampsia
Pregnancy
Prognosis
Young Adult
PAPR Study Consortium
Biomedical and clinical sciences
Language
Abstract
Development of effective prevention and treatment strategies for pre-eclampsia is limited by the lack of accurate methods for identification of at-risk pregnancies. We performed small RNA sequencing (RNA-seq) of maternal serum extracellular RNAs (exRNAs) to discover and verify microRNAs (miRNAs) differentially expressed in patients who later developed pre-eclampsia. Sera collected from 73 pre-eclampsia cases and 139 controls between 17 and 28 weeks gestational age (GA), divided into separate discovery and verification cohorts, are analyzed by small RNA-seq. Discovery and verification of univariate and bivariate miRNA biomarkers reveal that bivariate biomarkers verify at a markedly higher rate than univariate biomarkers. The majority of verified biomarkers contain miR-155-5p, which has been reported to mediate the pre-eclampsia-associated repression of endothelial nitric oxide synthase (eNOS) by tumor necrosis factor alpha (TNF-α). Deconvolution analysis reveals that several verified miRNA biomarkers come from the placenta and are likely carried by placenta-specific extracellular vesicles.